A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Asai A, Oshima Y, Yamamoto Y, Uochi TA, Kusaka H, Akinaga S, Yamashita Y, Pongracz K, Pruzan R, Wunder E, Piatyszek M, Li S, Chin AC, Harley CB, Gryaznov S.
Asai A, et al.
Cancer Res. 2003 Jul 15;63(14):3931-9.
Cancer Res. 2003.
PMID: 12873987